Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort.
- DOI
- 10.1177/13524585241302170
- Published
- 2025 Jan
- Container
- Multiple sclerosis (Houndmills, Basingstoke, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/13524585241302170,
title = {Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort.},
author = {Giovannoni G and Boyko A and Correale J and Edan G and Freedman MS and Montalban X and Rammohan K and Stefoski D and Yamout B and Leist T and Aydemir A and Borsi L and Verdun di Cantogno E},
year = {2025},
journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
doi = {10.1177/13524585241302170},
url = {https://doi.org/10.1177/13524585241302170}
}RIS
TY - JOUR TI - Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort. AU - Giovannoni G AU - Boyko A AU - Correale J AU - Edan G AU - Freedman MS AU - Montalban X AU - Rammohan K AU - Stefoski D AU - Yamout B AU - Leist T AU - Aydemir A AU - Borsi L AU - Verdun di Cantogno E PY - 2025 JO - Multiple sclerosis (Houndmills, Basingstoke, England) DO - 10.1177/13524585241302170 UR - https://doi.org/10.1177/13524585241302170 ER -
APA
G, G., A, B., J, C., G, E., MS, F., X, M., K, R., D, S., B, Y., T, L., A, A., L, B., & E, V. D. C. (2025). Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/13524585241302170
Source records
- pubmed · retrieved 2026-09-26T08:35:06.039Z